These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 29893681)

  • 41. New onset postoperative atrial fibrillation and early anticoagulation after cardiac surgery.
    Maaroos M; Pohjantähti-Maaroos H; Halonen J; Vähämetsä J; Turtiainen J; Rantonen J; Hakala T; Mennander AA; Hartikainen J
    Scand Cardiovasc J; 2017 Dec; 51(6):323-326. PubMed ID: 28990803
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vernakalant hydrochloride for the treatment of atrial fibrillation.
    Kozlowski D; Budrejko S; Lip GY; Mikhailidis DP; Rysz J; Raczak G; Banach M
    Expert Opin Investig Drugs; 2009 Dec; 18(12):1929-37. PubMed ID: 19938903
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chemical cardioversion of recent-onset atrial fibrillation in the emergency department using vernakalant hydrochloride achieves safe and rapid restoration of sinus rhythm and facilitates same day discharge.
    Stoneman P; Gilligan P; Mahon P; Sheahan R
    Ir J Med Sci; 2017 Nov; 186(4):903-908. PubMed ID: 28168639
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and Safety of Vernakalant for Cardioversion of Recent-onset Atrial Fibrillation in the Asia-Pacific Region: A Phase 3 Randomized Controlled Trial.
    Beatch GN; Bhirangi K; Juul-Moller S; Rustige J
    J Cardiovasc Pharmacol; 2017 Feb; 69(2):86-92. PubMed ID: 27828791
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vernakalant hydrochloride to treat atrial fibrillation.
    Brown RA; Lau YC; Lip GY
    Expert Opin Pharmacother; 2014 Apr; 15(6):865-72. PubMed ID: 24617913
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Atrial selective effects of intravenously administered vernakalant in conscious beagle dogs.
    Bechard J; Pourrier M
    J Cardiovasc Pharmacol; 2011 Jul; 58(1):49-55. PubMed ID: 21753258
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preoperative serum soluble receptor activator of nuclear factor-κB ligand and osteoprotegerin predict postoperative atrial fibrillation in patients undergoing cardiac valve surgery.
    Cao H; Zhou Q; Wu Y; Li Q; Røe OD; Chen Y; Wu Z; Wang D
    Ann Thorac Surg; 2013 Sep; 96(3):800-6. PubMed ID: 23870696
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Population pharmacokinetics of vernakalant hydrochloride injection (RSD1235) in patients with atrial fibrillation or atrial flutter.
    Mao ZL; Townsend RW; Gao Y; Wheeler JJ; Kastrissios H; Keirns J
    J Clin Pharmacol; 2012 Jul; 52(7):1042-53. PubMed ID: 21659624
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fragmented QRS may predict postoperative atrial fibrillation in patients undergoing isolated coronary artery bypass graft surgery.
    Çetin M; Kocaman SA; Erdoğan T; Durakoğlugil ME; Çiçek Y; Bozok Ş; Çanga A; Temiz A; Doğan S; Şatıroğlu Ö
    Anadolu Kardiyol Derg; 2012 Nov; 12(7):576-83. PubMed ID: 22804979
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The new antiarrhythmic drug vernakalant: ex vivo study of human atrial tissue from sinus rhythm and chronic atrial fibrillation.
    Wettwer E; Christ T; Endig S; Rozmaritsa N; Matschke K; Lynch JJ; Pourrier M; Gibson JK; Fedida D; Knaut M; Ravens U
    Cardiovasc Res; 2013 Apr; 98(1):145-54. PubMed ID: 23341576
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New-onset atrial fibrillation predicts long-term newly developed atrial fibrillation after coronary artery bypass graft.
    Lee SH; Kang DR; Uhm JS; Shim J; Sung JH; Kim JY; Pak HN; Lee MH; Joung B
    Am Heart J; 2014 Apr; 167(4):593-600.e1. PubMed ID: 24655710
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hemodynamic parameters predict the risk of atrial fibrillation after cardiac surgery in adults.
    Lu R; Ma N; Jiang Z; Mei J
    Clin Cardiol; 2017 Nov; 40(11):1100-1104. PubMed ID: 28850679
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and safety of vernakalant in recent-onset atrial fibrillation after the European medicines agency approval: systematic review and meta-analysis.
    Buccelletti F; Iacomini P; Botta G; Marsiliani D; Carroccia A; Gentiloni Silveri N; Franceschi F
    J Clin Pharmacol; 2012 Dec; 52(12):1872-8. PubMed ID: 22167572
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic factors of atrial fibrillation following coronary artery bypass graft surgery.
    Kievišas M; Keturakis V; Vaitiekūnas E; Dambrauskas L; Jankauskienė L; Kinduris Š
    Gen Thorac Cardiovasc Surg; 2017 Oct; 65(10):566-574. PubMed ID: 28647801
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Termination of Vernakalant-Resistant Atrial Fibrillation by Inhibition of Small-Conductance Ca
    Diness JG; Skibsbye L; Simó-Vicens R; Santos JL; Lundegaard P; Citerni C; Sauter DRP; Bomholtz SH; Svendsen JH; Olesen SP; Sørensen US; Jespersen T; Grunnet M; Bentzen BH
    Circ Arrhythm Electrophysiol; 2017 Oct; 10(10):e005125. PubMed ID: 29018164
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preoperative Electrocardiogram Score for Predicting New-Onset Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery.
    Gu J; Andreasen JJ; Melgaard J; Lundbye-Christensen S; Hansen J; Schmidt EB; Thorsteinsson K; Graff C
    J Cardiothorac Vasc Anesth; 2017 Feb; 31(1):69-76. PubMed ID: 27554222
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vernakalant, a mixed sodium and potassium ion channel antagonist that blocks K(v)1.5 channels, for the potential treatment of atrial fibrillation.
    Billman GE
    Curr Opin Investig Drugs; 2010 Sep; 11(9):1048-58. PubMed ID: 20730700
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased preoperative serum apoptosis marker fas ligand correlates with histopathology and new-onset of atrial fibrillation in patients after cardiac surgery.
    Müller P; Deneke T; Schiedat F; Bösche L; Strauch J; Dietrich JW; Vogt M; Tannapfel A; Stiegler H; Mügge A; Ewers A
    J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1110-5. PubMed ID: 23790081
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vernakalant: a new drug to treat patients with acute onset atrial fibrillation.
    Tian D; Frishman WH
    Cardiol Rev; 2011; 19(1):41-4. PubMed ID: 21135602
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impaired myocardium energetics associated with the risk for new-onset atrial fibrillation after isolated coronary artery bypass graft surgery.
    Sun DM; Yuan X; Wei H; Zhu SJ; Zhang P; Zhang SJ; Fan HG; Li Y; Zheng Z; Liu XC
    Coron Artery Dis; 2014 May; 25(3):224-9. PubMed ID: 24463787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.